DNTH — DIANTHUS THERAPEUTICS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 280 家机构在其最新 13F 申报中持有 DNTH(DIANTHUS THERAPEUTICS INC),合计申报市值 $6.61B,对应 70.42M 股。按股数计算较上季度增持 14.2%(+8.31M 股),申报市值环比上升 31.1%。持仓集中度较高:前五大持有人占申报市值的 33.4%,前十大的集中度为 49.9%。
与上一季度相比,67 家新建仓位、118 家加仓、69 家减仓、36 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
DIANTHUS THERAPEUTICS INC(DNTH)的主要机构持有人包括 Fidelity Management & Research (FMR)、BlackRock Inc、T. Rowe Price Investment Management, Inc.,按 13F 申报市值在本页 395 家持有人中排名居前。
DNTH 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
持有 DNTH 的传奇投资人
我们追踪的超级投资人在各自最新 13F 申报中持有 DNTH 的名单——每位投资人按其自身最近一个季度展示。
| 投资人 | 季度 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|---|
|
|
Q3 2026 | 24.93K | $2.19M | 0.02% | 增持 |
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 187 | 32.14M | $2.83B | +12.7% |
| Q2 2026 | 280 | 70.42M | $6.61B | +14.2% |
| Q1 2026 | 249 | 65.58M | $5.37B | +7.2% |
| Q4 2025 | 171 | 52.04M | $2.12B | +9.1% |
| Q3 2025 | 143 | 48.93M | $1.92B | +15.2% |
| Q2 2025 | 103 | 39.61M | $737.67M | +5.2% |
| Q1 2025 | 98 | 37.48M | $680.95M | +0.9% |
| Q4 2024 | 92 | 34.87M | $759.96M | +3.5% |
表内 8 个季度中,机构持股合计减少 8%(Q4 2024 → Q3 2026);单季变动最大的是 Q3 2025(+15.2%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 8.55M | $753.07M | 0.04% | 增持 | |
| 4.39M | $386.50M | 0.01% | 增持 | |
| 2.53M | $223.15M | 0.01% | 增持 | |
| 2.43M | $213.79M | 0.00% | 增持 | |
| 1.54M | $135.99M | 0.01% | 增持 | |
| 1.42M | $125.39M | 0.01% | 增持 | |
| 1.19M | $105.10M | 0.04% | 增持 | |
| 1.11M | $95.02M | 0.02% | 增持 | |
| 732.25K | $64.47M | 0.08% | 增持 | |
| 474.25K | $41.76M | 0.14% | 增持 | |
| 462.29K | $40.70M | 0.04% | 增持 | |
| 390.52K | $34.39M | 0.01% | 增持 | |
| 354.82K | $31.24M | 4.97% | 持有 | |
| 350.00K | $30.82M | 1.44% | 减持 | |
| 296.19K | $26.08M | 0.08% | 减持 | |
| 272.86K | $24.03M | 0.01% | 增持 | |
| 263.92K | $23.24M | 0.01% | 增持 | |
| 247.49K | $21.79M | 0.60% | 持有 | |
| 242.96K | $21.39M | 0.00% | 减持 | |
| 236.58K | $20.83M | 2.65% | 减持 | |
| 225.26K | $19.83M | 0.28% | 持有 | |
| 204.63K | $17.84M | 0.01% | 减持 | |
| 185.82K | $16.36M | 0.03% | 减持 | |
| 181.29K | $16.02M | 0.07% | 减持 | |
| 166.30K | $14.64M | 0.00% | 增持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 1.26M 股 · $122.70M
- Sixth Street Partners Management Company, L.P. 365.96K 股 · $35.67M
- WESTFIELD CAPITAL MANAGEMENT CO LP 314.91K 股 · $30.70M
- Assenagon Asset Management S.A. 280.65K 股 · $27.36M
- EMERALD ADVISERS, LLC 247.81K 股 · $24.16M
- TimesSquare Capital Management, LLC 166.36K 股 · $16.22M
- Eagle Health Investments LP 131.34K 股 · $12.80M
- EMERALD MUTUAL FUND ADVISERS TRUST 131.02K 股 · $12.77M
- ORBIMED ADVISORS LLC 115.00K 股 · $11.21M
- Two Sigma Investments 107.45K 股 · $10.47M
- FIRST TRUST ADVISORS LP 94.15K 股 · $9.18M
- MERCER GLOBAL ADVISORS INC /ADV 65.68K 股 · $6.40M
完全清仓(较上季)
- RA CAPITAL MANAGEMENT, L.P. 卖出 2.61M 股 · $219.18M
- STATE STREET CORP 卖出 1.40M 股 · $117.40M
- Farallon Capital Management 卖出 836.00K 股 · $70.16M
- FARALLON CAPITAL MANAGEMENT, L.L.C. 卖出 836.00K 股 · $70.16M
- Point72 Asset Management 卖出 643.60K 股 · $54.01M
- Freestone Grove Partners LP 卖出 239.94K 股 · $20.14M
- Integral Health Asset Management, LLC 卖出 150.00K 股 · $12.59M
- ExodusPoint Capital Management, LP 卖出 85.53K 股 · $7.18M
- Nantahala Capital Management, LLC 卖出 67.28K 股 · $5.65M
- ADAR1 Capital Management, LLC 卖出 55.00K 股 · $4.62M
- Evergreen Quality Fund GP, Ltd. 卖出 50.00K 股 · $4.20M
- Squarepoint Ops LLC 卖出 38.74K 股 · $3.25M
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 8.55M | 8.20M | 7.77M | 6.43M | 5.97M | 4.54M | 4.48M | 4.44M | 4.40M | 4.40M | 4.16M | 2.22M | 2.22M |
| BlackRock Inc | 4.39M | 4.12M | 3.18M | 1.92M | 1.34M | 1.36M | 1.62M | 1.65M | 1.64M | — | — | — | — |
| STATE STREET CORP | 2.53M | — | 1.40M | 1.51M | 671.05K | 820.14K | 759.68K | 818.84K | 821.13K | 407.71K | 20.40K | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.43M | 2.16M | 2.03M | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.54M | 570.12K | 349.38K | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 1.42M | 1.26M | 916.21K | 676.66K | 536.41K | 484.90K | 517.02K | 486.26K | 485.12K | 498.92K | 74.40K | 45.18K | 26.34K |
| UBS Group AG | 1.19M | 1.14M | 781.28K | 606.62K | 137.07K | 131.48K | 47.43K | 53.86K | 28.43K | 8.41K | 14.51K | 380 | 319 |
| Franklin Resources | 1.11M | 968.98K | 968.18K | 462.83K | 450.31K | — | — | — | — | — | — | — | — |
| Assenagon Asset Management S.A. | 732.25K | 280.65K | — | — | — | — | — | — | — | — | — | — | — |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 474.25K | 314.91K | — | — | — | — | — | — | — | — | — | — | — |
| Pictet Asset Management Holding SA | 462.29K | 247.29K | 4.92K | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 390.52K | 302.48K | 249.68K | — | — | — | — | — | — | — | — | — | — |
| Spruce Street Capital LP | 354.82K | 354.82K | 373.27K | 297.44K | — | — | — | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 350.00K | 400.00K | 50.00K | 115.00K | 262.10K | — | — | — | — | — | — | — | — |
| LORD, ABBETT & CO. LLC | 296.19K | 422.19K | 299.21K | — | — | — | — | — | — | — | — | — | — |
| Fisher Asset Management, LLC | 272.86K | 23.35K | 12.62K | 13.95K | — | — | — | — | — | — | — | — | — |
| BNY Mellon | 263.92K | 256.39K | 188.41K | 75.13K | 62.43K | 66.71K | 73.64K | 72.89K | 73.02K | 80.94K | 8.43K | — | — |
| EMERALD ADVISERS, LLC | 247.49K | 247.81K | — | — | — | — | — | — | — | — | — | — | — |
| DIMENSIONAL FUND ADVISORS LP | 242.96K | 321.50K | 325.44K | 210.67K | 8.69K | — | — | — | — | 19.73K | 21.73K | 14.74K | — |
| SILVERARC CAPITAL MANAGEMENT, LLC | 236.58K | 390.00K | 654.75K | 750.14K | 674.97K | 95.81K | 190.33K | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold DNTH?
As of 2026-Q2, 280 institutional funds reported holding DNTH (DIANTHUS THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $6.61B.
How many shares of DNTH do institutions own?
13F filers reported 70.42M shares of DNTH, worth $6.61B in aggregate at the end of 2026-Q2.
Is institutional ownership of DNTH rising or falling?
Share counts moved +14.2% versus the prior quarter — accumulation.
Who are the top institutional holders of DNTH?
The largest 13F holders are Fidelity Management & Research (FMR), BlackRock Inc, T. Rowe Price Investment Management, Inc., Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP; the top 25 are ranked at the top of this page.
Who are the major shareholders of DIANTHUS THERAPEUTICS INC?
The major shareholders of DIANTHUS THERAPEUTICS INC (DNTH) by reported 13F value are Fidelity Management & Research (FMR), BlackRock Inc, T. Rowe Price Investment Management, Inc., Wellington Management Group, WELLINGTON MANAGEMENT GROUP LLP, among 395 institutional holders.
Which legendary investors own DNTH?
1 of the legendary investors tracked on HoldingsHub report DNTH (DIANTHUS THERAPEUTICS INC) in their latest 13F filings, led by Polen Capital Management. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on DNTH?
1 tracked superinvestors hold DNTH simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.